Trial
NCT06568302
The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
ApcinteX Ltd
Collaborators
Centessa Pharmaceuticals plc
Condition
Hemophilia a
Intervention
SerpinPC
Why stopped
Study terminated due to business and strategic decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-10